[Recurrent failed ICD therapy of ventricular tachycardia]
W Hein1, U Ellringmann, D Vollmann
1Abteilung Kardiologie und internistische Intensivmedizin, Klinikum Werra-Meißner Eschwege, Elsa-Brändström-Straße 1, Eschwege, Germany. waldemarhein@hotmail.com
Implantable cardioverter defibrillators (ICD) can fail to detect slow ventricular tachycardia (VT) when patients are treated with amiodarone. VT ablation successfully resolved arrhythmia recurrences in a challenging case.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death in heart failure patients.
- Physicians frequently encounter challenges managing ICD therapy in emergency and intensive care settings.
Observation:
- A case involved a patient with recurrent ventricular tachycardia (VT) treated with amiodarone.
- Increasing amiodarone dosage progressively prolonged VT cycle length, rendering it undetectable by the ICD.
Findings:
- Slowed VT due to amiodarone therapy posed a diagnostic and therapeutic challenge for ICD monitoring.
- Ventricular tachycardia ablation was successfully performed, leading to complete resolution of arrhythmia recurrences.
Implications:
- This case highlights the potential for antiarrhythmic drugs to interfere with ICD efficacy.
- VT ablation can be an effective strategy for managing drug-refractory or ICD-undetectable arrhythmias.
- Careful consideration of drug interactions and alternative therapies is essential in complex ICD management scenarios.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias II: Classification of Tachyarrhythmias

